{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:06:19Z","timestamp":1784873179433,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtn.2024.102310","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:59:04Z","timestamp":1723737544000},"page":"102310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Aptamer-decorated nanocarriers for viral adsorption: A special look at COVID-19"],"prefix":"10.1016","volume":"35","author":[{"given":"Somayeh","family":"Handali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6823-2463","authenticated-orcid":false,"given":"Mohsen","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102310_bib1","first-page":"105","article-title":"The role of nanotechnology in the treatment of viral infections","volume":"4","author":"Singh","year":"2017","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.omtn.2024.102310_bib2","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1039\/D3SC00439B","article-title":"Aptamers 101: aptamer discovery and in\u00a0vitro applications in biosensors and separations","volume":"14","author":"Yang","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.omtn.2024.102310_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12038-016-9632-y","article-title":"Application of aptamers in diagnostics, drug-delivery and imaging","volume":"41","author":"Chandola","year":"2016","journal-title":"J.\u00a0Biosci."},{"key":"10.1016\/j.omtn.2024.102310_bib4","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.3390\/cancers15215300","article-title":"Aptamers as potential therapeutic tools for ovarian cancer: Advancements and challenges","volume":"15","author":"Szymanowski","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.omtn.2024.102310_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2018.07.003","article-title":"Aptamers: Uptake mechanisms and intracellular applications","volume":"134","author":"Yoon","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2024.102310_bib6","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1038\/mtna.2015.30","article-title":"Pharmacokinetics of a cholesterol-conjugated aptamer against the hepatitis C virus (HCV) NS5B protein","volume":"4","author":"Lee","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102310_bib7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3389\/fphar.2017.00922","article-title":"The evaluation of pharmacodynamics and pharmacokinetics of anti-thrombin DNA aptamer RA-36","volume":"8","author":"Zavyalova","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtn.2024.102310_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/molecules25010003","article-title":"Aptamers chemistry: Chemical modifications and conjugation strategies","volume":"25","author":"Odeh","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2024.102310_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2024.102310_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1021\/bc980002x","article-title":"Liposome-anchored vascular endothelial growth factor aptamers","volume":"9","author":"Willis","year":"1998","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2024.102310_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119971","article-title":"Tumor microenvironment (TME)-activatable circular aptamer-PEG as an effective hierarchical-targeting molecular medicine for photodynamic therapy","volume":"246","author":"Yang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2024.102310_bib12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/nano10050852","article-title":"On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges","volume":"10","author":"Sivasankarapillai","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.omtn.2024.102310_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bab.1563","article-title":"DNAzyme\u2013aptamer or aptamer\u2013DNAzyme paradigm: Biochemical approach for aflatoxin analysis","volume":"65","author":"Jafari","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.omtn.2024.102310_bib14","article-title":"Optimization of aflatoxin B1 aptasensing","volume":"2017","author":"Jafari","year":"2017","journal-title":"J.\u00a0Toxicol."},{"key":"10.1016\/j.omtn.2024.102310_bib15","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1039\/b906788d","article-title":"RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein","volume":"134","author":"Ahn","year":"2009","journal-title":"Analyst"},{"key":"10.1016\/j.omtn.2024.102310_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114436","article-title":"An electrochemical aptasensor with N protein binding aptamer-complementary oligonucleotides as probe for ultra-sensitive detection of COVID-19","volume":"213","author":"Yu","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.omtn.2024.102310_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113595","article-title":"Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrode-aptamer-SARS-CoV-2 imaging by photo-induced force microscopy","volume":"195","author":"Abrego-Martinez","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.omtn.2024.102310_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112942118","article-title":"A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry","volume":"118","author":"Valero","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102310_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.chembiol.2022.01.009","article-title":"Generation of an anticoagulant aptamer that targets factor V\/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples","volume":"29","author":"Soule","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.omtn.2024.102310_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.03.186","article-title":"Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1","volume":"90","author":"Telwatte","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2024.102310_bib21","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1039\/C9MH00628A","article-title":"Functionalized branched polymers: promising immunomodulatory tools for the treatment of cancer and immune disorders","volume":"6","author":"Moura","year":"2019","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.omtn.2024.102310_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802233","article-title":"T-Cell-Mimicking Nanoparticles Can Neutralize HIV Infectivity","volume":"30","author":"Wei","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2024.102310_bib23","doi-asserted-by":"crossref","first-page":"7912","DOI":"10.3390\/molecules18077912","article-title":"Dendrimers as potential therapeutic tools in HIV inhibition","volume":"18","author":"Peng","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2024.102310_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-57608-4","article-title":"Antiviral potential of 3\u2032-sialyllactose-and 6\u2032-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses","volume":"10","author":"G\u00fcnther","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102310_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113691","article-title":"Nef neutralizes the ability of exosomes from CD4+ T\u00a0cells to act as decoys during HIV-1 infection","volume":"9","author":"de Carvalho","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102310_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-42150-9","article-title":"poly (N-vinylcaprolactam) Nanogels with Antiviral Behavior against HIV-1 Infection","volume":"9","author":"Macchione","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102310_bib27","series-title":"The use of chitosan polymer in the treatment and prevention of infections caused by coronaviruses","author":"Pyrc","year":"2015"},{"key":"10.1016\/j.omtn.2024.102310_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biomaterials.2016.08.018","article-title":"Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection","volume":"106","author":"Chen","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2024.102310_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwac124","article-title":"Nanotechnology for the management of COVID-19 during the pandemic and in the post-pandemic era","volume":"9","author":"Xu","year":"2022","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.omtn.2024.102310_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41565-022-01177-2","article-title":"A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination","volume":"17","author":"Zhang","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2024.102310_bib31","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.3390\/molecules28135190","article-title":"Broad-spectrum, potent, and durable ceria nanoparticles inactivate RNA virus infectivity by targeting virion surfaces and disrupting virus\u2013receptor interactions","volume":"28","author":"Fox","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2024.102310_bib32","article-title":"Silver nanoparticle based multifunctional approach for combating COVID-19","volume":"2","author":"Allawadhi","year":"2021","journal-title":"Sens. Int."},{"key":"10.1016\/j.omtn.2024.102310_bib33","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1021\/acsnano.8b07902","article-title":"Intrinsic antibacterial activity of nanoparticles made of \u03b2-cyclodextrins potentiates their effect as drug nanocarriers against tuberculosis","volume":"13","author":"Machelart","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2024.102310_bib34","article-title":"Cholesterol and COVID19 lethality in elderly","author":"Wang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2024.102310_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.micinf.2006.10.015","article-title":"Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle","volume":"9","author":"Li","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.omtn.2024.102310_bib36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.idc.2019.07.001","article-title":"Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features","volume":"33","author":"Hui","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.omtn.2024.102310_bib37","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1021\/acsomega.9b02988","article-title":"Probing Nanoparticle\u2013Cell Interaction Using Micro-Raman Spectroscopy: Silver and Gold Nanoparticle-Induced Stress Effects on Optically Trapped Live Red Blood Cells","volume":"5","author":"Barkur","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.omtn.2024.102310_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/scipharm91030037","article-title":"Chitosan-based nanocarriers for delivery of remdesivir","volume":"91","author":"Milkova","year":"2023","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.omtn.2024.102310_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100119","article-title":"Controlled release nanomedicine (CRNM) of aspirin using \u201cbiomimetic niosomal nanoparticles (BNNs)\u201d for Covid-19 and cardiovascular treatment: DOE based optimization","volume":"9","author":"Rajeev","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.omtn.2024.102310_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cbdd.13978","article-title":"Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study","volume":"99","author":"Saify Nabiabad","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.omtn.2024.102310_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2019.104152","article-title":"A universal strategy designed for selecting bench-to-bedside aptamers to serum and validated in hepatocellular carcinoma diagnosis","volume":"150","author":"Wang","year":"2019","journal-title":"Microchem. J."},{"key":"10.1016\/j.omtn.2024.102310_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biochi.2020.02.007","article-title":"An aptamer-based, fluorescent and radionuclide dual-modality probe","volume":"171\u2013172","author":"Zhang","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.omtn.2024.102310_bib43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","article-title":"Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence","volume":"14","author":"Alshawwa","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2024.102310_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/cells11010159","article-title":"Aptamer-enabled nanomaterials for therapeutics, drug targeting and imaging","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2024.102310_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2018.10.008","article-title":"Pharmacokinetics, pharmacodynamics and safety of aptamers","volume":"134","author":"Kovacevic","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2024.102310_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.327","article-title":"Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models","volume":"4","author":"Xuan","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.omtn.2024.102310_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124173","article-title":"Advances in aptamer-mediated targeted delivery system for cancer treatment","volume":"238","author":"He","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.omtn.2024.102310_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1118546","article-title":"Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer","volume":"11","author":"Deng","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102310_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103663","article-title":"Harnessing aptamers against COVID-19: A therapeutic strategy","volume":"28","author":"Mahmoudi","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtn.2024.102310_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1785","article-title":"Aptamers as promising nanotheranostic tools in the COVID-19 pandemic era","volume":"14","author":"Dzuvor","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2024.102310_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110902","article-title":"Aptamers used for biosensors and targeted therapy","volume":"132","author":"Ning","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2024.102310_bib52","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/ijms21072485","article-title":"Antibodies, nanobodies, or aptamers\u2014which is best for deciphering the proteomes of non-model species?","volume":"21","author":"Dhar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102310_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13036-019-0223-y","article-title":"SELEX tool: a novel and convenient gel-based diffusion method for monitoring of aptamer-target binding","volume":"14","author":"Liu","year":"2020","journal-title":"J.\u00a0Biol. Eng."},{"key":"10.1016\/j.omtn.2024.102310_bib54","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2174\/1568026615666150413153143","article-title":"Peptide aptamers: development and applications","volume":"15","author":"Reverdatto","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.omtn.2024.102310_bib55","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1038\/emm.2016.44","article-title":"Aptamer\u2013nanoparticle complexes as powerful diagnostic and therapeutic tools","volume":"48","author":"Jo","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omtn.2024.102310_bib56","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3390\/ph6121507","article-title":"Aptamer-based therapeutics: new approaches to combat human viral diseases","volume":"6","author":"Shum","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.omtn.2024.102310_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.20","article-title":"Inhibition of influenza virus replication by DNA aptamers targeting a cellular component of translation initiation","volume":"5","author":"Rodriguez","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102310_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jinf.2018.04.007","article-title":"Oligonucleotide aptamers: promising and powerful diagnostic and therapeutic tools for infectious diseases","volume":"77","author":"Pan","year":"2018","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.omtn.2024.102310_bib59","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/cbic.201600014","article-title":"Biomedical Applications of DNA-Conjugated Gold Nanoparticles","volume":"17","author":"Wang","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.omtn.2024.102310_bib60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.omtn.2017.10.009","article-title":"Targeting herpes simplex virus-1 gD by a DNA aptamer can be an effective new strategy to curb viral infection","volume":"9","author":"Yadavalli","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102310_bib61","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.str.2018.06.001","article-title":"Structure of an RNA aptamer that can inhibit HIV-1 by blocking Rev-cognate RNA (RRE) binding and Rev-Rev association","volume":"26","author":"Dearborn","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.omtn.2024.102310_bib62","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bbrc.2007.12.020","article-title":"Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase\/Helicase","volume":"366","author":"Jang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2024.102310_bib63","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/cbic.200800491","article-title":"Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase","volume":"9","author":"Shum","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.omtn.2024.102310_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.abb.2019.07.004","article-title":"Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles","volume":"671","author":"Saravanakumar","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.omtn.2024.102310_bib65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejpb.2017.01.011","article-title":"Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer","volume":"114","author":"Powell","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.omtn.2024.102310_bib66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2014.12.035","article-title":"Epithelial cell adhesion molecule aptamer conjugated PEG\u2013PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in\u00a0vitro","volume":"479","author":"Alibolandi","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2024.102310_bib67","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/nat.2013.0469","article-title":"Characterization of an RNA aptamer against HPV-16 L1 virus-like particles","volume":"24","author":"Leija-Montoya","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2024.102310_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00604-021-04858-2","article-title":"Specific determination of HBV using a viral aptamer molecular imprinting polymer sensor based on ratiometric metal organic framework","volume":"188","author":"Wang","year":"2021","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.omtn.2024.102310_bib69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.omtn.2021.06.014","article-title":"A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2","volume":"26","author":"Gupta","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102310_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05421","article-title":"Aptamer BC 007-Efficient binder of spreading-crucial SARS-CoV-2 proteins","volume":"6","author":"Weisshoff","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.omtn.2024.102310_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-021-00649-6","article-title":"Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtn.2024.102310_bib72","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1039\/D0SC03920A","article-title":"A serological aptamer-assisted proximity ligation assay for COVID-19 diagnosis and seeking neutralizing aptamers","volume":"11","author":"Liu","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.omtn.2024.102310_bib73","doi-asserted-by":"crossref","first-page":"32877","DOI":"10.1021\/acsomega.3c04137","article-title":"Development of Rapid Aptamer-Based Screening Assay for the Detection of Covid-19 Variants","volume":"8","author":"Aloraij","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.omtn.2024.102310_bib74","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1038\/s41598-024-58315-0","article-title":"A new DNA aptamer which binds to SARS-CoV-2 spike protein and reduces pro-inflammatory response","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T06:37:13Z","timestamp":1730529433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124001975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2162253124001975"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102310","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer-decorated nanocarriers for viral adsorption: A special look at COVID-19","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102310"}}